Sofosbuvir
1 NDC across 1 manufacturer|0 Generic,1 Brand
Sofosbuvir is used to treat chronic hepatitis c, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 6, 2013, and the first generic was approved Jan 27, 2022. In 2024, Medicare Part D spent $2 million on Sofosbuvir across 81 claims for 23 beneficiaries.
Sofosbuvir is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $975.30 to $975.30 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$975.30 – $975.30
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Gilead Sciences, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing SOFOSBUVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SOVALDI 400 MG TABLET | $975.3000 per EA | — |
Frequently Asked Questions
What is Sofosbuvir used to treat?
Sofosbuvir is used to treat chronic hepatitis c, per the National Library of Medicine's MED-RT classification.
When did Sofosbuvir become available as a generic?
FDA approved the first generic Sofosbuvir (ANDA) on Jan 27, 2022.
How much does Medicare spend on Sofosbuvir?
In 2024, Medicare Part D spent $2 million on Sofosbuvir across 81 claims for 23 beneficiaries.
How many Sofosbuvir products are on the market?
The Sofosbuvir drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Sofosbuvir?
NADAC reference prices for Sofosbuvir range from $975.3000 to $975.3000 per EA.
Which manufacturers make Sofosbuvir?
1 manufacturer lists Sofosbuvir in NADAC. Ranked by number of NDCs, the largest are Gilead Sciences, Inc. (1).